The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global breast implant market was valued at US$ 2.48 Billion in 2021.
We expect the global breast implant market to exhibit a CAGR of 4.60% during 2022-2027.
The high prevalence of breast cancer is leading towards the growing demand for implants in breast
reconstruction procedures, which is primarily driving the global breast implant market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective surgeries, such as
breast implant procedures, to reduce the risk of coronavirus infection upon hospital visits or interaction
with healthcare professionals or medical equipment.
Based on the product, the global breast implant market can be segmented into silicone breast implants
and saline breast implants, where silicone breast implants currently hold the majority of the total
Based on the application, the global breast implant market has been divided into cosmetic surgery and
reconstructive surgery. Currently, cosmetic surgery exhibits a clear dominance in the market.
Based on the end user, the global breast implant market can be categorized into hospitals, cosmetology
clinics, and ambulatory surgical centers. Among these, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global breast implant market include Allergan plc, CEREPLAS,
Establishment Labs SA, Global Consolidated Aesthetics Limited, Groupe Sebbin SAS, HansBiomed Co.
Ltd., Ideal Implant Inc., Laboratoires Arion, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH
Health & Aesthetics GmbH, and Sientra Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at